Home > Insider Trading > Filing (0001209191-23-047880)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1662774	Quince Therapeutics Inc.	QNCX	Biological Products, (No Disgnostic Substances) (2836)	901024039

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1770790	David Lamond	C/O Quince Therapeutics, Inc. 601 Gateway Blvd, Ste. Suite 1250 South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-08-30	41,026	$1.31	2,138,135	No	4	P	Indirect	By Blue Devil Trust dated 12/03/2010
Common Stock	Acquisiton	2023-08-31	41,026	$1.32	2,179,161	No	4	P	Indirect	By Blue Devil Trust dated 12/03/2010

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Blue Devil Trust dated 12/03/2010
No	4	P	Indirect	By Blue Devil Trust dated 12/03/2010

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	301,829	Direct
Common Stock	1,734,722	Indirect	By David A. Lamond Trust dated 2006

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.30 to $1.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the "Trust") and holds sole voting and dispositive power with respect to the shares held of record by the Trust.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.29 to $1.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Mr. Lamond is the trustee of David A. Lamond Trust dated 2006 (the "2006 Trust") and holds sole voting and dispositive power with respect to the shares held of record by the 2006 Trust.